Top compounds associated with response to TPD52L1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.11 0.01
mRNA foretinib GDSC1000 pan-cancer AAC -0.11 0.01
mRNA methylstat CTRPv2 pan-cancer AAC -0.11 0.01
mRNA Erlotinib gCSI pan-cancer AAC 0.17 0.01
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA PFI-1 GDSC1000 pan-cancer AAC 0.11 0.01
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA BMS-708163 GDSC1000 pan-cancer AAC 0.11 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.02
Download CSV